Literature DB >> 35046104

The Protective Role of IL-36/IL-36R Signal in Con A-Induced Acute Hepatitis.

Xiaofang Wang1,2, Yuejin Liang2,3, Hui Wang4, Biao Zhang2,5, Lynn Soong2,3,4, Jiyang Cai6, Panpan Yi7, Xuegong Fan7, Jiaren Sun8,3,4.   

Abstract

The IL-36 family, including IL-36α, IL-36β, IL-36γ, and IL-36R antagonist, belong to the IL-1 superfamily. It was reported that IL-36 plays a role in immune diseases. However, it remains unclear how IL-36 regulates inflammation. To determine the role of IL-36/IL-36R signaling pathways, we established an acute hepatitis mouse model (C57BL/6) by i.v. injection of the plant lectin Con A. We found that the levels of IL-36 were increased in the liver after Con A injection. Our results demonstrated the infiltrated neutrophils, but not the hepatocytes, were the main source of IL-36 in the liver. Using the IL-36R-/- mouse model (H-2b), we surprisingly found that the absence of IL-36 signals led to aggravated liver injury, as evidenced by increased mortality, elevated serum alanine aminotransferase and aspartate aminotransferase levels, and severe liver pathological changes. Further investigations demonstrated that a lack of IL-36 signaling induced intrahepatic activation of CD4+ and CD8+ T lymphocytes and increased the production of inflammatory cytokines. In addition, IL-36R-/- mice had reduced T regulatory cell numbers and chemokines in the liver. Together, our results from the mouse model suggested a vital role of IL-36 in regulating T cell function and homeostasis during liver inflammation.
Copyright © 2022 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35046104      PMCID: PMC8830780          DOI: 10.4049/jimmunol.2100481

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  65 in total

1.  Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis.

Authors:  Alexandros Onoufriadis; Michael A Simpson; Andrew E Pink; Paola Di Meglio; Catherine H Smith; Venu Pullabhatla; Jo Knight; Sarah L Spain; Frank O Nestle; A David Burden; Francesca Capon; Richard C Trembath; Jonathan N Barker
Journal:  Am J Hum Genet       Date:  2011-08-11       Impact factor: 11.025

2.  Interleukin-36 cytokines enhance the production of host defense peptides psoriasin and LL-37 by human keratinocytes through activation of MAPKs and NF-κB.

Authors:  Toan The Nguyen; François Niyonsaba; Hiroko Ushio; Toshihiro Akiyama; Chanisa Kiatsurayanon; Rithee Smithrithee; Shigaku Ikeda; Ko Okumura; Hideoki Ogawa
Journal:  J Dermatol Sci       Date:  2012-08-09       Impact factor: 4.563

3.  IL-37 suppresses the sustained hepatic IFN-γ/TNF-α production and T cell-dependent liver injury.

Authors:  Xin-Xia Feng; Gang Chi; Han Wang; Yuan Gao; Qian Chen; Ying-Xia Ru; Zhen-Long Luo; Wei Yan; Pei-Yuan Li; Mei Liu; Zuo-Hua Feng; De-An Tian
Journal:  Int Immunopharmacol       Date:  2019-02-05       Impact factor: 4.932

4.  Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2.

Authors:  R Debets; J C Timans; B Homey; S Zurawski; T R Sana; S Lo; J Wagner; G Edwards; T Clifford; S Menon; J F Bazan; R A Kastelein
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

5.  Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis.

Authors:  Slaheddine Marrakchi; Philippe Guigue; Blair R Renshaw; Anne Puel; Xue-Yuan Pei; Sylvie Fraitag; Jihen Zribi; Elodie Bal; Céline Cluzeau; Maya Chrabieh; Jennifer E Towne; Jason Douangpanya; Christian Pons; Sourour Mansour; Valérie Serre; Hafedh Makni; Nadia Mahfoudh; Faiza Fakhfakh; Christine Bodemer; Josué Feingold; Smail Hadj-Rabia; Michel Favre; Emmanuelle Genin; Mourad Sahbatou; Arnold Munnich; Jean-Laurent Casanova; John E Sims; Hamida Turki; Hervé Bachelez; Asma Smahi
Journal:  N Engl J Med       Date:  2011-08-18       Impact factor: 91.245

6.  Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.

Authors:  M-A Boutet; G Bart; M Penhoat; J Amiaud; B Brulin; C Charrier; F Morel; J-C Lecron; M Rolli-Derkinderen; A Bourreille; S Vigne; C Gabay; G Palmer; B Le Goff; F Blanchard
Journal:  Clin Exp Immunol       Date:  2016-02-22       Impact factor: 4.330

7.  IL-36α expression is elevated in ulcerative colitis and promotes colonic inflammation.

Authors:  S E Russell; R M Horan; A M Stefanska; A Carey; G Leon; M Aguilera; D Statovci; T Moran; P G Fallon; F Shanahan; E K Brint; S Melgar; S Hussey; P T Walsh
Journal:  Mucosal Immunol       Date:  2016-01-27       Impact factor: 7.313

8.  Small Molecule IL-36γ Antagonist as a Novel Therapeutic Approach for Plaque Psoriasis.

Authors:  Viktor Todorović; Zhi Su; C Brent Putman; Stevan J Kakavas; Katherine M Salte; Heath A McDonald; Joseph B Wetter; Stephanie E Paulsboe; Qi Sun; Clare E Gerstein; Limary Medina; Bernhard Sielaff; Ramkrishna Sadhukhan; Henning Stockmann; Paul L Richardson; Wei Qiu; Maria A Argiriadi; Rodger F Henry; J Martin Herold; J Brad Shotwell; Steve P McGaraughty; Prisca Honore; Sujatha M Gopalakrishnan; Chaohong C Sun; Victoria E Scott
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

9.  IL-36 receptor deletion attenuates lung injury and decreases mortality in murine influenza pneumonia.

Authors:  T Aoyagi; M W Newstead; X Zeng; S L Kunkel; M Kaku; T J Standiford
Journal:  Mucosal Immunol       Date:  2016-12-14       Impact factor: 7.313

10.  IκBζ is a key transcriptional regulator of IL-36-driven psoriasis-related gene expression in keratinocytes.

Authors:  Anne Müller; André Hennig; Sebastian Lorscheid; Paula Grondona; Klaus Schulze-Osthoff; Stephan Hailfinger; Daniela Kramer
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-17       Impact factor: 11.205

View more
  1 in total

1.  AhR Activation Leads to Attenuation of Murine Autoimmune Hepatitis: Single-Cell RNA-Seq Analysis Reveals Unique Immune Cell Phenotypes and Gene Expression Changes in the Liver.

Authors:  Alkeiver S Cannon; Bryan Latrell Holloman; Kiesha Wilson; Kathryn Miranda; Nicholas Dopkins; Prakash Nagarkatti; Mitzi Nagarkatti
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.